PCI Startup Vital Start Health Wins 2022 Citizens Small Business Community Champions Award for their Work in Neonatal Care
PCI startup Vital Start Health empowers clinicians and caregivers by giving them a digital platform to improve neonatal care.
PCI Startup ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System
Tumors within the heart affect thousands of patients around the world annually, but prior to the ŌNŌ system, open-heart surgery was the only way to remove them.
Funding Opportunity for Climate-Focused Faculty or Student Startups
Exelon Corporation and the non-profit Exelon Foundation are searching for promising early-stage companies to invest in for the 4th annual Climate Change Investment Initiative (2c2i).
President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022
Lumify Care and Neuralert have grown rapidly in terms of funding and product expansion.
Penn Graduate Receives President’s Sustainability Prize for Robotics-Based System to Minimize Waste in Fishing Industry
Shinkei Systems cuts down on waste by reducing the likelihood that off-target species would be caught and killed, and streamlining the process to avoid waste.
Penn Spinout REGENXBIO Inc. Enters Commercial Phase; Focuses Gene Therapy on Common Cause of Blindness
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
Carisma Therapeutics CEO Steve Kelly Wins Entrepeneur of the Year for Greater Philadelphia Region
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.
Local Startups Participate in Pennovation Accelerator Program
Learn about the cohort of local startups participating in the fifth annual Pennovation Accelerator.
Philadelphia Ranked as One of the Top Startup Ecosystems in the United States
Startup Genome described Philly as "a vibrant Life Science hub and a particularly attractive home base for female entrepreneurs."
Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.